1. Home
  2. CLWT vs VIVS Comparison

CLWT vs VIVS Comparison

Compare CLWT & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLWT

Euro Tech Holdings Company Limited

N/A

Current Price

$1.22

Market Cap

9.2M

ML Signal

N/A

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

N/A

Current Price

$2.10

Market Cap

5.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLWT
VIVS
Founded
1971
2007
Country
Hong Kong
United States
Employees
N/A
13
Industry
Professional and commerical equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
5.0M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
CLWT
VIVS
Price
$1.22
$2.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.4K
211.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
$17.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$1.42
52 Week High
$1.63
$5.30

Technical Indicators

Market Signals
Indicator
CLWT
VIVS
Relative Strength Index (RSI) 50.79 49.52
Support Level $1.20 $1.75
Resistance Level $1.30 $2.17
Average True Range (ATR) 0.05 0.16
MACD 0.00 0.01
Stochastic Oscillator 75.00 55.51

Price Performance

Historical Comparison
CLWT
VIVS

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: